Redeye updates its estimates for Mestro, which reported a strong Q4 2022, with an accelerated growth rate and a couple of larger contracts. Mestro is executing on its growth targets and is now seeking to scale its margins as well. We raise our base case one notch.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

Attachments

Mestro - Accelerating growth

© Modular Finance, source Nordic Press Releases